QPX7728, An Ultra-Broad-Spectrum B-Lactamase Inhibitor for Intravenous and Oral Therapy: Overview of Biochemical and Microbiological Characteristics

Overview of attention for article published in Frontiers in Microbiology, July 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

policy: 1 policy source

twitter: 3 X users

Citations

dimensions_citation: 29 Dimensions

Readers on

mendeley: 49 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 27,227 followers.

RT @A_baumannii: QPX7728, An Ultra-Broad-Spectrum B-Lactamase Inhibitor for Intravenous and Oral Therapy: Overview of Biochemical and Micro…

27 Jul 2021

Reply Repost Favourite

QPX7728, An Ultra-Broad-Spectrum B-Lactamase Inhibitor for Intravenous and Oral Therapy: Overview of Biochemical and Microbiological Characteristics https://t.co/iwdNxbJgKh https://t.co/qq6QB5Ty9w

22 Jul 2021

Reply Repost Favourite

New Research: QPX7728, An Ultra-Broad-Spectrum B-Lactamase Inhibitor for Intravenous and Oral Therapy: Overview of Biochemical and Microbiological Characteristics https://t.co/RkdWAUVH0B #microbiology

13 Jul 2021

Reply Repost Favourite

Recently published in @FrontMicrobiol , our β-lactamase inhibitor QPX7728 showed to have the broadest spectrum of enzyme inhibition in a single BLI molecule, including broad coverage of high priority #drugresistant pathogens as named by @WHO . #IDtwitter h

09 Jul 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.